These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 8549868)
21. Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial. Simonyi G Chin Med J (Engl); 2016 May; 129(10):1224-8. PubMed ID: 27174332 [TBL] [Abstract][Full Text] [Related]
22. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy. Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602 [TBL] [Abstract][Full Text] [Related]
23. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066 [TBL] [Abstract][Full Text] [Related]
24. Renal protection and antihypertensive drugs: current status. Salvetti A; Mattei P; Sudano I Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294 [TBL] [Abstract][Full Text] [Related]
25. Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade. Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A Am J Hypertens; 1996 Sep; 9(9):850-3. PubMed ID: 8879340 [TBL] [Abstract][Full Text] [Related]
26. Blood pressure control, drug therapy, and kidney disease. Contreras G; Greene T; Agodoa LY; Cheek D; Junco G; Dowie D; Lash J; Lipkowitz M; Miller ER; Ojo A; Sika M; Wilkening B; Toto RD; Hypertension; 2005 Jul; 46(1):44-50. PubMed ID: 15897360 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers. Nosadini R; Tonolo G J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317 [TBL] [Abstract][Full Text] [Related]
28. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Ecder T; Chapman AB; Brosnahan GM; Edelstein CL; Johnson AM; Schrier RW Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268 [TBL] [Abstract][Full Text] [Related]
29. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
30. Patterns of renal injury in NIDDM patients with microalbuminuria. Fioretto P; Mauer M; Brocco E; Velussi M; Frigato F; Muollo B; Sambataro M; Abaterusso C; Baggio B; Crepaldi G; Nosadini R Diabetologia; 1996 Dec; 39(12):1569-76. PubMed ID: 8960844 [TBL] [Abstract][Full Text] [Related]
31. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta. Breithaupt-Grögler K; Leschinger M; Belz GG; Butzer R; Erb K; de May C; Sinn W Cardiovasc Drugs Ther; 1996 Mar; 10(1):49-57. PubMed ID: 8723170 [TBL] [Abstract][Full Text] [Related]
32. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication. Jeffers BW; Robbins J; Bhambri R; Wajsbrot D Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570 [TBL] [Abstract][Full Text] [Related]
33. Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide. Scaglione R; Ganguzza A; Corrao S; Costa R; Paternà S; Cannavo MG; Parrinello G; Di Chiara T; D'Aubert MD; Cottone C Blood Press; 1995 Nov; 4(6):363-8. PubMed ID: 8746604 [TBL] [Abstract][Full Text] [Related]
34. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Bakris GL; Copley JB; Vicknair N; Sadler R; Leurgans S Kidney Int; 1996 Nov; 50(5):1641-50. PubMed ID: 8914031 [TBL] [Abstract][Full Text] [Related]
35. Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study. Rachmani R; Levi Z; Slavachevsky I; Half-Onn E; Ravid M Nephron; 1998 Oct; 80(2):175-82. PubMed ID: 9736816 [TBL] [Abstract][Full Text] [Related]
36. The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group. Rodby RA; Rohde RD; Clarke WR; Hunsicker LG; Anzalone DA; Atkins RC; Ritz E; Lewis EJ Nephrol Dial Transplant; 2000 Apr; 15(4):487-97. PubMed ID: 10727543 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial. Ando K; Ueshima K; Tanaka S; Kosugi S; Sato T; Matsuoka H; Nakao K; Fujita T Int J Med Sci; 2013; 10(9):1209-16. PubMed ID: 23935398 [TBL] [Abstract][Full Text] [Related]